People · Operator
Named in public records as an officer, director or promoter · active 2007–2025 · Other Technology, Other Health Care, Biotechnology, Other Energy, Other, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| WellTok, Inc. | — | Other Technology | Series C | $385.1M | $499.9M | 2010 |
| HALT Medical, Inc | — | Other Health Care | Series C | $177.7M | $1.4B | 2007 |
| Aspira Women's Health Inc. | — | Biotechnology | Series C | $80.0M | $16.6M | 2025 |
| Neurologica Corp | — | Biotechnology | Series A | $17.0M | $433.8M | 2008 |
| ZapGo Ltd. | — | Other Energy | Series A | $13.3M | $59.7M | 2018 |
| School of Rock, LLC | — | Other | Series A | $10.7M | $10.6M | 2009 |
| Photo Diagnostic Systems, Inc. | — | Other | Series A | $5.0M | $75.7M | 2010 |
| Thrive Software, Inc. | — | Software / Tech | Pre-Seed | $900K | $16.1M | 2021 |
| Leadoff.ai, Inc. | — | AI / ML | Pre-Seed | $500K | $3.0M | 2024 |
| G-SNAP!, Inc. | — | Other Technology | Pre-Seed | $430K | $18.2M | 2008 |
Jeffrey Cohen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeffrey Cohen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Miles Arnone | 1 | 12 |
| Matthew Ross | 1 | 8 |
| Dustin Smith | 1 | 6 |
| ROBERT STEWART | 1 | 6 |
| James S. Burns | 1 | 5 |
| Bernard M. Gordon | 1 | 5 |
| Gordon O'Brien | 1 | 4 |
| James Burns | 1 | 4 |
| Bernard Gordon | 1 | 4 |
| Raymond Stata | 1 | 4 |
| Paul Green | 1 | 3 |
| Jeffrey Margolis | 1 | 3 |
| STEFANIE CAVANAUGH | 1 | 3 |
| Jay Goldberg | 1 | 3 |
| John F. Hamilton | 1 | 3 |
| Khaled J. Nasr | 1 | 3 |
| Shoshana Vernick | 1 | 3 |
| Lynn O'Connor Vos | 1 | 3 |
| Kimberly Reed | 1 | 2 |
| Scott Rotermund | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.